Cyclo-RGD Truncated Polymeric Nanoconstruct with Dendrimeric Templates for Targeted HDAC4 Gene Silencing in Diabetic Nephropathy Mouse Model

60 Pages Posted: 20 Sep 2019

See all articles by Nidhi Raval

Nidhi Raval

National Institute of Pharmaceutical Education and Research (NIPER), Department of Pharmaceuticals

Hardi Jogi

National Institute of Pharmaceutical Education and Research (NIPER), Department of Pharmaceuticals

Piyush Gondaliya

National Institute of Pharmaceutical Education and Research (NIPER), Department of Pharmaceuticals

Kiran Kalia

National Institute of Pharmaceutical Education and Research (NIPER), Department of Pharmaceuticals

Rakesh K. Tekade

National Institute of Pharmaceutical Education and Research (NIPER), Department of Pharmaceuticals

Abstract

Diabetic Nephropathy (DN), a chronic progressive kidney disease, is a major complication of diabetes mellitus. Dysregulation of histone deacetylases (HDACs) gene has been implicated in the pathogenesis of DN. Hence, the HDAC-inhibitors have emerged as a novel class of therapeutic agents in DN, however, the currently available HDAC4-inhibitors are mostly nonselective in nature as well as inhibit multiple HDACs. RNA interference of HDAC4 (HDAC4 siRNA) has shown immense promise, but the clinical translation has been impeded due to lack of a targeted, specific and in vivo applicable delivery modality. In the present investigation, we examined Cyclo(RGDfC) (cRGD) truncated polymeric nanoplex with dendrimeric templates for targeted HDAC4 Gene Silencing. The developed nanoplex exhibited enhance encapsulation of siRNA and offered superior protection against serum RNase nucleases degradation. The nanoplex was tested on podocytes (in vitro) wherein it showed selective binding to the αvβ3 integrin receptor, effective cellular uptake and significant in vitro gene silencing. The in vivo experiments showed remarkable suppression of the HDAC4 and inhibition in the progression of renal fibrosis in STZ induced DN C57BL/6 mice model. Histopathological and toxicological studies revealed non-significant abnormality/toxicity with the nanoplex. Conclusively, nanoplex was found as a promising tactic for targeted therapy of podocytes and could be extended for other kidney related ailments.

Keywords: Gene silencing, siRNA delivery, Diabetic nephropathy, Polymeric nanoplex, In vitro Podocytes Diabetic nephropathy, Diabetic Nephropathy mice model

Suggested Citation

Raval, Nidhi and Jogi, Hardi and Gondaliya, Piyush and Kalia, Kiran and Tekade, Rakesh K., Cyclo-RGD Truncated Polymeric Nanoconstruct with Dendrimeric Templates for Targeted HDAC4 Gene Silencing in Diabetic Nephropathy Mouse Model. Available at SSRN: https://ssrn.com/abstract=3454943 or http://dx.doi.org/10.2139/ssrn.3454943

Nidhi Raval

National Institute of Pharmaceutical Education and Research (NIPER), Department of Pharmaceuticals

India

Hardi Jogi

National Institute of Pharmaceutical Education and Research (NIPER), Department of Pharmaceuticals

India

Piyush Gondaliya

National Institute of Pharmaceutical Education and Research (NIPER), Department of Pharmaceuticals

India

Kiran Kalia

National Institute of Pharmaceutical Education and Research (NIPER), Department of Pharmaceuticals

India

Rakesh K. Tekade (Contact Author)

National Institute of Pharmaceutical Education and Research (NIPER), Department of Pharmaceuticals ( email )

India

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
54
Abstract Views
446
Rank
676,215
PlumX Metrics